DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 12301 - 12325 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name ▼ UniProt ID
C0027651 Neoplasms GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C1956346 Coronary Artery Disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0028754 Obesity GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0036341 Schizophrenia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0699791 Stomach Carcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0020456 Hyperglycemia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0017638 Glioma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0278701 Gastric Adenocarcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0010054 Coronary Arteriosclerosis GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0023467 Leukemia, Myelocytic, Acute GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0524620 Metabolic Syndrome X GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0039483 Giant Cell Arteritis GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C1306459 Primary malignant neoplasm GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0010068 Coronary heart disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0342883 Cholesteryl Ester Transfer Protein Deficiency GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0410529 Hypochondroplasia (disorder) GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0020538 Hypertensive disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0024623 Malignant neoplasm of stomach GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0007137 Squamous cell carcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0020473 Hyperlipidemia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0010346 Crohn Disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0038454 Cerebrovascular accident GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0007134 Renal Cell Carcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0948008 Ischemic stroke GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0555198 Malignant Glioma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024